Marc Martinell Pedemonte

This inventor holds 19 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 11 EPO patents. Top assignees: Oryzon Genomics S.a., Minoryx Therapeutics S.l.. Active years: 2015-2026.

USPTO Granted Patents = 19 (Patent Applications = 13)

% Patents Active = 78.9

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 24)

Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 132(Granted Patents)

Company Filing History:

Minoryx Therapeutics S.l.

patents

Years Active: 2015-2026

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673048 - Method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione (2026-07-07),

2. 11957670 - 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseases (2024-04-16),

3. 11938122 - 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease (2024-03-26),

4. 11440898 - Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidase (2022-09-13),

5. 10329256 - (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors (2019-06-25),

6. 10233178 - Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use (2019-03-19),

7. 10214477 - (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors (2019-02-26),

8. 10179126 - 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders (2019-01-15),

9. 9944601 - (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors (2018-04-17),

10. 9908859 - Lysine demethylase inhibitors for myeloproliferative disorders (2018-03-06),

11. 9782395 - 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders (2017-10-10),

12. 9708309 - Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use (2017-07-18),

13. 9676701 - Cyclopropylamine derivatives useful as LSD1 inhibitors (2017-06-13),

14. 9670136 - (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors (2017-06-06),

15. 9487512 - (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors (2016-11-08),

Title: Marc Martinell Pedemonte - Innovative Inventor from Barcelona

Introduction: Marc Martinell Pedemonte is a renowned inventor hailing from Barcelona, Spain, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Marc Martinell Pedemonte holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of interests and expertise.

Career Highlights: With a successful career spanning over two decades, Marc Martinell Pedemonte has established himself as a pioneer in the world of inventions, with numerous accolades and recognitions for his impactful work.

Collaborations: Throughout his career, Marc Martinell Pedemonte has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge sharing.

Conclusion: Marc Martinell Pedemonte's passion for innovation and his relentless pursuit of excellence continue to inspire aspiring inventors and shape the future of technology and beyond.